New and Improved Navitor Makes for a Serious TAVR Contender

(MedPage Today) — NEW YORK CITY — The newer Navitor looked increasingly viable as a transcatheter aortic valve replacement (TAVR) system, based on its largest report of commercial use to date.
In the U.S., the Navitor Vision was associated…